The auditing agency questions the lack of business rationality in multiple Business activities, while ST Chuntian warns of "increased risk" and hits the lower limit.

①ST Chuntian has multiple Business operations questioned by the auditing institution for lack of commercial rationale, and the company's 2024 annual report may be issued with an inability to express an opinion or a negative opinion. ② The auditing institution has preliminarily determined that ST Chuntian's adjusted or deducted revenue will be less than 0.3 billion yuan, triggering a financial risk warning for being (Delisted). ③ ST Chuntian stated that it will cooperate with the relevant auditing work and provide sufficient audit evidence to eliminate the auditors' concerns.

cls.cnApr 17 02:03 ET

TJ DaRenTang is clearing out the "profit milk cow". What is the impact of this on future performance? | Quick read announcement.

① TJ DaRenTang announced its plan to transfer its 12% equity stake in Sino-American Schering for 1.623 billion yuan, liquidating this "cash cow." ② The company stated that this Trade aligns with its development strategy focused on its main business, which is beneficial for increasing the company's Cash / Money Market Inflow.

cls.cnApr 15 09:43 ET

Brokerage morning meeting highlights: Countermeasures against tariffs boost Shenzhen Agricultural Products Group prices, the planting chain directly benefits.

At today's Brokerage morning meeting, CITIC SEC believes that countermeasures against tariffs boost the prices of Shenzhen Agricultural Products Group, which directly benefits the planting chain; HAITONG SEC proposed a bullish view on the relative yields of the Banks Sector in April; Galaxy Securities stated that it focuses on Gold and countermeasures against rare earths.

cls.cnApr 7 20:33 ET

Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.

In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.

cls.cnApr 6 20:17 ET

The entire pharmaceutical sector has surged sharply; what happened?

On Monday, all AH Stocks in the pharmaceutical Sector surged, with innovative drugs performing the strongest. The Yinhua CSI Innovative Drugs Industry ETF collectively rose sharply, driven by three main factors: the relaxation of collective procurement, overseas license authorizations, and improvement in Earnings Reports that will reshape the Industry landscape.

wallstreetcnApr 1 08:38 ET

The Social Security Fund's annual report on Hold Positions has been revealed! A total of 52 new stocks entered the top ten circulating Shareholders list, with China Resources Double-Crane Pharmaceutical receiving the most Shareholding increases.

① With the continuous disclosure of the 2024 annual reports of listed companies, the Social Security Fund has newly entered the top ten circulating shareholders list of 52 individual stocks; ② Among them, China Resources Double-Crane Pharmaceutical has the highest number of new holdings by the Social Security Fund, reaching 3; ③ Attached is the list of A-shares where the number of newly added Institutions held by the Social Security Fund in the fourth quarter of 2024 ranks highest (attached table).

cls.cnMar 29 04:55 ET